NFE2L2 and pituitary gland adenoma: Previous studies have shown that the expression of Nrf2 and phosphorylated Nrf2 is elevated in pituitary adenomas [52], along with the downstream effector HO-1, indicating the activation of the Nrf2 signaling pathway and its potential role in the development of pituitary adenoma cells [53].